Oral CELMoD agent (unspecified)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Oral CELMoD agent (unspecified), covering 2026-03-30 to 2026-03-30. Get the full timeline:
Most recent: Clinical Trial Update: Study of Intravenously (IV) Infused Etentamig in Combination With an Oral Cereblon E3 Ligase Modulatory Drug (CELMoD) Agent Assessing Adverse Events and Change in Disease Activity in Adult Participants With Relapsed or Refractory Multiple Myeloma [Phase 1]